These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2415970)

  • 1. Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments.
    Fulcher CA; de Graaf Mahoney S; Roberts JR; Kasper CK; Zimmerman TS
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7728-32. PubMed ID: 2415970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting.
    Fulcher CA; de Graaf Mahoney S; Zimmerman TS
    Blood; 1987 May; 69(5):1475-80. PubMed ID: 2436689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization.
    Scandella D; Mattingly M; de Graaf S; Fulcher CA
    Blood; 1989 Oct; 74(5):1618-26. PubMed ID: 2477082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide.
    Ware J; MacDonald MJ; Lo M; de Graaf S; Fulcher CA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):703-16. PubMed ID: 1283342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.
    Scandella DH; Nakai H; Felch M; Mondorf W; Scharrer I; Hoyer LW; Saenko EL
    Thromb Res; 2001 Mar; 101(5):377-85. PubMed ID: 11297754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.
    Scandella D; Gilbert GE; Shima M; Nakai H; Eagleson C; Felch M; Prescott R; Rajalakshmi KJ; Hoyer LW; Saenko E
    Blood; 1995 Sep; 86(5):1811-9. PubMed ID: 7544643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII.
    Koshihara K; Qian J; Lollar P; Hoyer LW
    Blood; 1995 Sep; 86(6):2183-90. PubMed ID: 7662967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.
    Prescott R; Nakai H; Saenko EL; Scharrer I; Nilsson IM; Humphries JE; Hurst D; Bray G; Scandella D
    Blood; 1997 May; 89(10):3663-71. PubMed ID: 9160671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives.
    Ananyeva NM; Lacroix-Desmazes S; Hauser CA; Shima M; Ovanesov MV; Khrenov AV; Saenko EL
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):109-24. PubMed ID: 15090997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic antibodies to factor VIII in haemophilia A.
    Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S31-4. PubMed ID: 14567533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
    Nogami K; Shima M; Nishiya K; Sakurai Y; Tanaka I; Giddings JC; Saenko EL; Yoshioka A
    Thromb Haemost; 2002 Mar; 87(3):459-65. PubMed ID: 11916079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoblot analysis shows changes in factor VIII inhibitor chain specificity in factor VIII inhibitor patients over time.
    Fulcher CA; Lechner K; de Graaf Mahoney S
    Blood; 1988 Oct; 72(4):1348-56. PubMed ID: 2458782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII.
    Gensana M; Altisent C; Aznar JA; Casaña P; Hernández F; Jorquera JI; Magallón M; Massot M; Puig L
    Haemophilia; 2001 Jul; 7(4):369-74. PubMed ID: 11442641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    J Immunol Methods; 2006 Jan; 308(1-2):90-100. PubMed ID: 16376372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel factor VIII inhibitor epitopes using synthetic peptide arrays.
    Palmer DS; Dudani AK; Drouin J; Ganz PR
    Vox Sang; 1997; 72(3):148-61. PubMed ID: 9145485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
    Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.